Revakinagene tororetcel (Neurotech Pharmaceuticals Inc.) is an investigational ocular implant that delivers sustained therapeutic doses of ciliary neurotrophic factor to the retina to slow the progression of macular telangiectasia type 2.
Horizon Scanning
It is a challenge for health plans and clinicians to know what emerging technologies are in the preapproval phase and what their clinical, financial, and risk impacts might be. This is where we come in.The Hayes Horizon Scanning Solution identifies innovative and potentially disruptive health technologies that are in various stages of the regulatory approval process. Our Research Analysts continually investigate new technologies that are on the horizon or in the early stages of clinical investigation, as well as the testing of existing technologies that may be seeking approval for new clinical applications. Hayes Horizon Scanning helps you track emerging technologies before you need to make decisions. Accessed through the Hayes Knowledge Center, Hayes Horizon Scanning addresses the following fundamental questions to help our clients forecast emerging technologies:
- Is this emerging technology new or replacing an existing technology?
- Where is this technology in the FDA regulatory process?
- When will this technology be commercially available in the market?
- What is the projected use, cost, and financial impact of this technology?
Corvia Atrial Shunt (Corvia Medical Inc.) for Heart Failure
The Corvia Atrial Shunt (formerly the InterAtrial Shunt Device [IASD]; Corvia Medical Inc.) is a transcatheter interatrial shunt under investigation for treatment of heart failure with preserved or midrange ejection fraction.
FSYX Ocular Pressure Adjusting Pump (Balance Ophthalmics Inc.) for Open-Angle Glaucoma
The FSYX Ocular Pressure Adjusting Pump (Balance Ophthalmics Inc.) is a negative pressure eye goggle indicated for reducing intraocular pressure (IOP) during sleep in adult patients with open-angle glaucoma and IOP ≤ 21 millimeters of mercury who are currently using or have undergone another IOP-lowering treatment.
Donanemab (Kisunla; Eli Lilly and Co.) for Alzheimer Disease
Donanemab (Kisunla; Eli Lilly and Co.) is an intravenously administered amyloid beta-directed antibody indicated for the treatment of Alzheimer disease. Treatment with donanemab should be initiated in patients with mild cognitive impairment or mild dementia stage of disease.
Eladocagene Exuparvovec (PTC Therapeutics) for Aromatic L-amino Acid Decarboxylase Deficiency
Eladocagene exuparvovec (PTC Therapeutics) is an investigational gene replacement therapy administered by intraputaminal infusion for the treatment of aromatic L-amino acid decarboxylase deficiency with a severe phenotype in patients aged 18 months and older.
pro2cool (TecTraum Inc.) for Mild Traumatic Brain Injury
The pro2cool device is a portable head and neck cooling device under investigation for the treatment of adolescent mild traumatic brain injury (mTBI; concussion).
Pulmonary Artery Denervation (PADN) Catheter (Pulnovo Medical) for Pulmonary Arterial Hypertension
The Pulnovo Pulmonary Artery Denervation (PADN) catheter is an investigational pulmonary artery catheter intended for radiofrequency ablation of pulmonary nerves to treat pulmonary arterial hypertension (PAH) in adults.
Encoberminogene Rezmadenovec (XyloCor Therapeutics Inc.) for Refractory Angina Pectoris
Encoberminogene rezmadenovec (XyloCor Therapeutics Inc.) is an investigational gene therapy proposed for treatment of refractory angina pectoris. The therapy is administered directly to cardiac muscle via minithoracotomy.
Bulevirtide (Gilead Sciences Inc.) for Chronic Hepatitis Delta Virus
Bulevirtide (Gilead Sciences Inc.) is an investigational, first-in-class, subcutaneously injected virion entry inhibitor proposed for the treatment of chronic hepatitis delta virus (HDV) infection in adults with compensated liver disease.
Etripamil (Milestone Pharmaceuticals) for Paroxysmal Supraventricular Tachycardia
Etripamil is an investigational, self-administered, calcium-channel blocker, nasal spray for rapid termination of paroxysmal supraventricular tachycardia outside of the healthcare setting.